Pediatric Cough/Cold Products Relabeled “Do Not Use” For Children Under 4
This article was originally published in The Pink Sheet Daily
Executive Summary
Voluntary effort based on AE data for 2-3-year-olds.
You may also be interested in...
Low-profile Cough/Cold/Allergy Meds Target Of Latest FDA Push Against Unapproved Rx Drugs
The agency doesn't know the drugs' share of the market, but uncertainties about their safety and efficacy constitute an untenable risk for consumers, CDER compliance chief says.
Low-profile Cough/Cold/Allergy Meds Target Of Latest FDA Push Against Unapproved Rx Drugs
The agency doesn't know the drugs' share of the market, but uncertainties about their safety and efficacy constitute an untenable risk for consumers, CDER compliance chief says.
Race For White Oak Almost Over: Will It End With Sharfstein Or Califf At FDA?
The Senate confirmation of a permanent FDA commissioner could come as early as March now that the Obama transition team has apparently concluded its search for Andrew von Eschenbach's successor